Overview
Philip Harraka practices in Clayton, Australia. Mr. Harraka is rated as an Experienced expert by MediFind in the treatment of Calcium Pyrophosphate Arthritis. His top areas of expertise are Glomerulonephritis, Alport Syndrome, Late-Onset Retinal Degeneration, and Henoch-Schonlein Purpura.
His clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Calcium Pyrophosphate Arthritis.
Locations
Epping, VIC 3076, Australia
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Alport SyndromeMr. Harraka isExperienced. Learn about Alport Syndrome.
- Bartter SyndromeMr. Harraka isExperienced. Learn about Bartter Syndrome.
- Calcium Pyrophosphate ArthritisMr. Harraka isExperienced. Learn about Calcium Pyrophosphate Arthritis.
- Focal Segmental GlomerulosclerosisMr. Harraka isExperienced. Learn about Focal Segmental Glomerulosclerosis.
- Gitelman SyndromeMr. Harraka isExperienced. Learn about Gitelman Syndrome.
- GlomerulonephritisMr. Harraka isExperienced. Learn about Glomerulonephritis.